Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, ...

No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...

Collaboration and License Revenue: Collaboration and license revenue for the third quarter ended September 30, 2024 was $10.0 million, as compared to zero for the same period in 2023. The increase was ...

Zealand Pharma A/S ( (ZLDPF) ) has released its Q3 earnings. Here is a breakdown of the information Zealand Pharma A/S presented to its ...

A hotel near the Danbury Fair Mall is for sale for $6.25 million, according to a listing from Coldwell Banker Commercial Realty. The 76,000-square-foot Maron Hotel & Suites, at 42 Lake Ave. Ext. in ...

Surrozen, Inc. ('Surrozen” or the 'Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced ...

Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...